Vascular endothelial growth factor (VEGF) is a potent vascular endothelial cell-specific mitogen that modulates endothelial cell function. In the present study, we show that VEGF induces manganese-superoxide dismutase (MnSOD) mRNA and protein in human coronary artery endothelial cells (HCAEC) and pulmonary artery endothelial cells. VEGF-mediated induction of MnSOD mRNA was inhibited by pretreatment with the NADPH oxidase inhibitors, diphenyleneiodonium (DPI), and 4-(2-aminoethyl)-benzenesulfonyl fluoride, but not with the nitric oxide synthase inhibitor L-NAME (N-monomethyl-L-arginine) or the xanthine oxidase inhibitor allopurinol. VEGF stimulation of MnSOD was also inhibited by adenoviral-mediated overexpression of catalase Cu, Zn-SOD and a dominant-negative form of the small GTPase component of NADPH oxidase Rac1 (Rac1N17). Treatment of HCAEC with VEGF resulted in a transient increase in ROS production at 20 min, as measured by 2´,7´-dichlorodihydrofluorescein oxidation. This effect was abrogated by expression of Rac1N17. Taken together, these findings suggest that VEGF induces MnSOD by an NADPH oxidase-dependent mechanism and that VEGF signaling in the endothelium is coupled to the redox state of the cell.
The superoxide dismutase (SOD) family includes cytosolic Cu, Zn-SOD, mitochondrial manganese SOD (MnSOD), and extracellular Cu, Zn-SOD (5). By converting superoxide to H 2 O 2 and O 2 , these enzymes inhibit free radical reactions that lead to oxidative damage. MnSOD is the primary antioxidant defense against superoxide radicals within the mitochondria (6) . Many studies have shown that increased cellular levels of MnSOD are protective against oxidative stress. Indeed, MnSOD expression is up-regulated by a variety of proinflammatory mediators, including lipopolysaccharide (LPS) (7) , tumor necrosis factor.71)-α) (7, 8) , interleukin-(7), interferon-α-thrombin (9) , and ionizing radiation (10) .
The importance of MnSOD in cell biology is evident in genetic mouse models in which the gene is either deleted or overexpressed. For example, mice that are null for the MnSOD gene are embryonic lethal and develop cardiomyopathy (11, 12) . However, overexpression of MnSOD is associated with suppression of spontaneous apoptosis (13) and protection against ischemic reperfusion injury in the heart (14) .
Vascular endothelial growth factor (VEGF) is a potent vascular endothelial cell-specific mitogen that induces physiological angiogenesis during embryogenesis and wound healing (15) (16) (17) (18) (19) (20) . VEGF has also been implicated in pathological states of angiogenesis, including proliferative diabetic retinopathy and solid tumor growth. In addition to its role in angiogenesis, VEGF has been shown to alter microvascular permeability, induce vasodilation, inhibit apoptosis, and promote cell migration.
In this study, we show that VEGF induces the expression of MnSOD mRNA and protein in cultured endothelial cells. This effect is dependent on basal and inducible levels of NADPH oxidase-derived ROS, which suggests that VEGF signaling is sensitive to the redox state of the endothelium.
MATERIALS AND METHODS

Cell culture
Human coronary artery endothelial cells (HCAEC) and human pulmonary artery endothelial cells (HPAEC) (Clonetics, San Diego, CA) were grown in the endothelial growth medium-2-MV (EGM-2-MV) BulletKit (Clonetics) at 37 Û C and 5% CO 2 . At 80%-90% confluence, the cells were serum-starved in medium containing EBM-2 (Clonetics) and 0.5% fetal bovine serum (FBS) for 12 h and subsequently treated with VEGF (Pepro Tech Inc., Rocky Hill, NJ) at the doses and for the times indicated.
Chemical inhibitors
HCAEC were serum-starved for 12 h, pretreated with ROS inhibitors for 30 min, and then incubated in the absence or presence of 50 ng/ml VEGF for the times indicated. We used the following ROS inhibitors: 1) oxygen free radical scavengers 0.3-5 mM anthrone (Acros Organics, Geel, Belgium) and 0.03%-3% DMSO (Sigma Chemical, St. Louis, MO); 2) xanthine oxidase inhibitor 0.1-0.5 mM allopurinol (Sigma); 3) NADPH oxidase inhibitors 2-0 diphenyleneiodonium (DPI; Biomol, Plymouth Meeting, PA), 0.25-1.0 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF; Sigma), and 0.03-3.0 mM 4-hydroxy-3-methoxyacetaphenone (apocynin; Sigma-Aldrich, Steinheim, Germany); 4) nitric oxide synthase (NOS) inhibitor 0.1-5.0 mM N-monomethyl-L-arginine (L-NAME; Sigma); and 5) mitochondrial (complex I) NADH dehydrogenase inhibitor 5-0 URWHQRQH 6LJPD DQG cytochrome P450 inhibitors 0.3-JPO PHWKR[DOHQ 6LJPD DQG 0 WUROHDQGRP\.LQ %LRPRO In other experiments, the superoxide donor phenazine methosulfate (0.5-0306%LRPRORU the NO donor S-nitroprusside (50-0 61$3 %LRPRO ZDV DGGHG WR VHUXP-starved HCAEC for 4 h. Cell viability, as measured by absolute cell counts and Trypan blue exclusion, was unaffected by the highest concentrations of DPI or AEBSF (data not shown).
Adenoviruses
HCAEC were infected with adenoviruses encoding the cDNAs of human catalase (AdCat), human Cu, Zn-SOD (AdSOD), and the Escherichia coli LacZ gene $GJDODVZHOODVWKHP\. epitope-tagged cDNA of the dominant-negative form of Rac1 (AdRac1N17), as previously described (21) . Infections were carried out at a multiplicity of infection (MOI) of 50 or 200 for 16 h. Infected cells were grown in complete medium for another 12 h, serum-starved in 0.5% FBS for 12 h, and then treated with VEGF for the times indicated.
Northern and Western blot analyses
Northern and Western blot analyses were carried out as previously described (22) . Northern blots were hybridized with [
32 P]dCTP-labeled human MnSOD, eNOS, or 18S ribosomal RNA probes, the Western blots with primary rabbit polyclonal anti-0Q62' ,J* JPO 8SVWDWH Biotechnology, Lake Placid), monoclonal anti-c-myc IgG, or polyclonal anti-Egr-1 IgG (Santa Cruz Biotechnology, Santa Cruz, CA). For actinomycin D experiments, we treated HCAEC cells ZLWKJPOD.WLQRP\.LQ'6LJPDIRUPLQEHIRUHDGGLQJQJPO9(*)DQGKDUYHVWHG them for total RNA 4 h later.
Measurement of intracellular ROS generation
We determined changes in intracellular ROS levels by measuring the oxidative conversion of cell-permeable 2´,7´-dichlorofluorescein diacetate (DCFH-DA; Molecular Probes Inc., Eugene, OR) to fluorescent dichlorofluorescein (DCF) by fluorescence-activated cell sorting (FACS) (23, 24) , or by confocal laser scanning microscopy as previously described (21) . For FACS assays, endothelial cells were grown in 10-cm plates, serum-starved overnight in 0.5% FBS, and treated either with VEGF or with agonists/antagonists of ROS generation for 1 h unless otherwise indicated. The cells were washed twice with prewarmed Hank's balanced salt solution (HBSS; /LIH7H.KQRORJLHV5R.NYLOOH0'DQGZHUHLQ.XEDWHGLQPO+%66.RQWDLQLQJ0'&)+-DA at 37Û& IRU PLQ &HOOV ZHUHWKHQZDVKHGZLWKL.H-cold HBSS, gently scraped from the plate, and resuspended in 1 ml HBSS. DCF fluorescence distribution of 20,000 cells was detected by FACS analysis at an excitation wavelength of 485 nm and at an emission wavelength of 530 nm. Nonviable cells, as identified by propidium iodide (PI) uptake, were excluded from the analysis. Each experiment was performed in triplicate and repeated at least two times with similar results. For confocal microscopy assays, HCAEC were infected with the indicated adenoviruses and incubated in the absence or presence of VEGF for the specified time. ROS were detected by fluorescence of DCFH-DA by using a Ziess confocal laser-scanning microscope as previously described (21) . Absolute fluorescence was quantitated on a scale of 0-255 with MetaMorph software. Results are shown from a representative experiment and are expressed as the mean ± SD of the absolute DCF of 20 random cells.
Migration assays
To test the effect of VEGF on the migration of virally infected HCAEC, we performed assays by using a modified Boyden chamber (Neuro Probe, Gaithersburg, MD). Infections were carried out at a MOI of 100 MOI for 16 h. Infected cells were grown in complete medium for 24 h and were serum-starved in 0.5% FBS for 12 h. The bottom 48-well plate was filled with EBM-2 media containing 0.2% FBS with or without 50 ng/ml VEGF. A polycarbonate filter pretreated with JPO ILEURQH.WLQ 6LJPD ZDV ODLG RYHU WKH ERWWRP SODWH DQG WKHQ .RYHUHG ZLWK WKH WRS plate. HCAEC were suspended in EBM-2 media containing 0.2% FBS and added to the top well at a density of 7,500 cells/well. The chamber was incubated at 37Û&IRUK7KH.HOOVRQWKHWRS of the membrane were removed, and the cells that had migrated to the bottom side were fixed and stained with Diff-Quik (Dade Behring, Buckinghamshire, U.K.). Cell migration was quantified by counting under light microscopy. Counts are reported as an average of cell number per mm 2 (n=6-12 per condition).
Cell viability assays
To determine whether adenoviral-mediated gene transfer induced changes in cell viability, FACS assays were carried out to measure binding of FITC-labeled annexin V (Clontech, Palo Alto, CA) to the early apoptotic marker phosphatidylserine. HCAEC were either uninfected or infected with AdJDORU$G5D.1DVGHV.ULEHGDERYHDWD02,RI7KH.HOOVZHUHVHUXP-starved in 0.5% FBS for 16 h, washed with phosphate buffered saline, harvested by trypsinization, and pooled with culture medium to include cells that had lost their adherent properties. After an extensive wash, ~1 × 10 6 cells were resuspended in 200 µl binding buffer per the manufacturer instructions. Annexin V-FITC was added to a final concentration of 500 ng/ml, and the cells were incubated at room temperature for 15 min in the dark. Following the addition of PI, at least 10,000 cells were analyzed by FACS at an excitation wavelength of 488 nm. Annexin Vnegative/PI-negative cells were assessed as viable, annexin V-positive/PI-negative as early apoptotic, and annexin V-positive/PI-positive as late apoptotic or necrotic. Cell viability was also assayed by Trypan blue exclusion. To that end, 1 × 10 6 uninfected or adenovirus-infected HCAEC were suspended in 2 ml of medium and 50 µl of this mixture was incubated with an equal volume of 0.4% Trypan blue (Sigma) for 5 min at room temperature. The cells were counted under light microscopy. The annexin V-FITC and Trypan blue exclusion assays were both performed in triplicate.
RESULTS
VEGF induces MnSOD mRNA and protein in cultured endothelial cells
In Northern blot analyses, MnSOD mRNA levels were increased in VEGF-treated HCAEC and HPAEC with peak levels occurring at 4 h (3.2±0.2 fold in HCAEC and 2.3±0.5 fold in HPAEC ) (Fig. 1A) . MnSOD transcripts remained elevated up to 24 h following VEGF treatment in both cell types. In contrast, eNOS mRNA was not induced in either cell type by the administration of VEGF (Fig. 1A ). This latter result is at odds with a previously published report in which VEGF was shown to induce eNOS mRNA in human umbilical vein endothelial cells (HUVEC) (25) . In dose-response studies in HCAEC, maximal induction of MnSOD mRNA occurred at 100 ng/ml VEGF (3.9±0.3 fold) (data not shown). Finally, to determine whether VEGF-mediated induction of MnSOD occurred at a transcriptional level, HCAEC were pretreated with 10 JPO actinomycin D for 30 min before a 4-h incubation with VEGF. Actinomycin D completely abolished VEGF-mediated induction of MnSOD mRNA (data not shown), indicating that MnSOD induction by VEGF requires de novo mRNA synthesis.
In Western blot analyses, MnSOD protein was induced significantly by VEGF in HCAEC and HPAEC, with maximal levels occurring at 24 h (4.4±1.2 fold in HCAEC and 4.3±0.8 fold in HPAEC) (Fig. 1B) . To confirm that the endothelial cells were responsive to VEGF at earlier time points, the membranes were stripped and reprobed for Egr-1. As shown in Figure 1B , VEGFmediated induction of Egr-1 occurred between 0.5 and 1 h. Taken together, the above results suggest that MnSOD is induced by VEGF at mRNA and protein levels. Given that the VEGF responses in HCAEC and HPAEC were comparable, we focused on HCAEC in the studies below.
VEGF-mediated induction of MnSOD is abrogated by chemical inhibitors of NADPH oxidase
In previous studies, LPS and TNF-α have been shown to induce MnSOD expression indirectly by increasing intracellular levels of ROS (26, 27) . To determine whether the response of MnSOD to VEGF in endothelial cells was mediated similarly by ROS, HCAEC were serum-starved and then either incubated with superoxide or NO donors or treated with VEGF in the absence or presence of ROS inhibitors. VEGF-mediated induction of MnSOD at 4 h was inhibited by the ROS scavengers anthrone (0.3-5.0 mM) (28) and DMSO (0.3%-3%) ( Fig. 2A, B, respectively) . To determine the primary source of ROS generation involved in this process, HCAEC were treated with different inhibitors of ROS before the addition of VEGF. VEGF-mediated induction of MnSOD was not inhibited by pretreatment with the xanthine oxidase inhibitor allopurinol (0.1-0.5 mM) ( Fig. 2A) or with the cytochrome P450 inhibitors methoxalen (0.3-3.0JPODQG WUROHDQGRP\.LQ 0 GDWD QRW VKRZQ +RZHYHU WKH HIIH.W RI 9(*) RQ 0Q62' ZDV inhibited in a dose-GHSHQGHQW PDQQHU E\ '3, DW .RQ.HQWUDWLRQV KLJKHU WKDQ 0 Fig. 2A) , implicating a role for one of the flavin-linked oxidases, namely NADPH oxidase (29, 30) and/or NOS (31) . To differentiate between these two pathways, HCAEC were treated with a structurally unrelated NADPH oxidase inhibitor AEBSF (0.25-1 mM) (32) and the NOS inhibitor L-NAME (5 mM). As shown in Figure 2B and C, the response to VEGF was abrogated by pretreatment with AEBSF, but not with L-NAME. Moreover, basal levels of MnSOD mRNA were not affected by the addition of the NO donor 61$3 0 Fig. 2C) . DPI has been shown to inhibit complex I in the mitochondria. To determine whether this effect was contributing to the pattern of DPI response, we preincubated HCAEC with the mitochondrial site I electron transport inhibitor rotenone. Pretreatment with rotenone resulted in a significant increase in MnSOD mRNA (data not shown). Considering these results, we speculate that the requirement for high doses of DPI to inhibit VEGF-mediated induction of MnSOD reflects the competing effects of this compound on NADPH oxidase and the mitochondrial complex I.
VEGF-mediated induction of MnSOD is inhibited by adenoviral-mediated overexpression of catalase Cu, Zn-SOD and Rac1N17
Taken together, the above studies suggest that VEGF induces MnSOD by an NADPH oxidasedependent mechanism. In view of the nonspecific actions of the chemical inhibitors, we wished to confirm these results by using genetic approaches. To that end, we used an adenoviral gene transfer system to infect HCAEC with control virus (AdJDORUZLWKYLUXV.RQWDLQLQJWKH.'1$ of catalase (AdCat) Cu, Zn-SOD (AdSOD) or a dominant negative form of the small GTPase component of NADPH oxidase Rac1 (AdRac1N17) at 50 MOI. Infection with AdRac1N17 was shown to result in significant expression of the myc-tagged protein in HCAEC, as measured by Western blot analysis (Fig. 3A) . As shown in Fig. 3B , VEGF-mediated induction of MnSOD mRNA was abrogated by the overexpression of catalase or Cu, Zn-SOD and significantly inhibited by expression of Rac1N17 compared with control (from sixfold to twofold). The Northern blot assays were repeated twice with similar results. Taken together, the findings suggest that the VEGF-mediated response of MnSOD is critically dependent on the redox state of the cell and is mediated in part by a Rac1-dependent oxidase.
Basal levels ROS in endothelial cells are generated by NADPH oxidase
To determine the relative contributions of the ROS-generating enzymes in endothelial cells, HCAEC were labeled with cell-permeable DCFH-DA, and oxidation of intracellular DCF was measured by FACS analysis. Baseline oxidation of the fluorophore was inhibited in a dosedependent manner by DPI and AEBSF, whereas 0DOORSXULQROKDGQRVX.KHIIH.WTable 1 7KH DGGLWLRQ RI 0 L-NAME resulted in a slight but significant increase in ROS generation, suggesting that NOS inhibition has a net prooxidant effect (Table 1) . This observation is consistent with a previous report in which L-NAME was shown to induce DCF R[LGDWLRQ LQ +89(& 3UHLQ.XEDWLRQ RI +&$(& ZLWK 0 DQWKURQH VLJQLIL.DQWO\ reduced ROS levels (data not shown). Treatment of HCAEC with agonists of ROS (100 nM 30$RU0306UHVXOWHGLQDVLJQLficant increase in DCF oxidation (Table 1 shows PMS). Taken together, these results suggest that the NADPH oxidase enzyme complex is responsible for generating ambient levels of ROS in HCAEC.
VEGF produces a transient increase in Rac1 oxidase-dependent ROS in endothelial cells
Using FACS analysis, we could not detect an increase in intracellular levels of ROS in VEGFtreated HCAEC (data not shown). However, previous studies have demonstrated a relatively rapid increase in intracellular ROS in vascular cells stimulated with growth factors and cytokines (21, 34) . Because DCF is rapidly oxidized and photobleached, the time elapsed between addition of DCF and FACS analysis may obscure an early effect of VEGF on ROS production. To address this issue, we used real-time confocal laser scanning microscopy to examine DCF fluorescence in HCAEC between 5 and 30 min following addition of VEGF. As shown in Figure   4 , VEGF resulted in a significant transient increase in ROS at 20 min (47% and 56% in uninfected and control $GJDO-infected HCAEC, respectively). This effect was abrogated completely by adenoviral-PHGLDWHG H[SUHVVLRQ RI $G5D.1 .RPSDUHG ZLWK .RQWURO $GJDO (Fig. 4) . Considering these findings, we conclude that VEGF produces a transient increase in Rac1 oxidase-dependent ROS.
Rac1-dependent oxidase is also necessary for VEGF-mediated migration of endothelial cells
We demonstrated recently that VEGF-induced migration of endothelial cells was suppressed by chemical inhibitors of NADPH oxidase (24) . To determine whether Rac1-dependent oxidase is involved in this response, HCAEC were infected with AdJDO$G&DWRU$G5D.1DQGZHUH assayed for chemotaxis in a Boyden chamber as previously described (24) . VEGF-mediated induction of migration was abolished by AdRac1N17 and significantly inhibited by overexpression of AdCat (Fig. 5A) . To exclude an effect of Rac1N17 on apoptosis and cell YLDELOLW\.HOOVWKDWZHUHHLWKHUXQLQIH.WHGRUWUDQVGX.HGZLWKWKH$GJDORU$G5D.1YLUXVHV (100 MOI) were assayed for annexin V binding and Trypan blue exclusion. In FACS analysis of annexin V-binding, the proportion of viable cells was 91%, 88%, and 91% in the uninfected, $GJDO-infected, and AdRacN17-infected cells, respectively. The proportion of early apoptotic cells was 1.2%, 2.4%, and 1%, respectively. The proportion of late apoptotic or necrotic cells was 2.8%, 5.1%, and 3.5%, respectively. In Trypan blue exclusion assays, there was no significant difference in viability between uninfected and infected cells (uninfected control, $GJDO-infected, 95.7%; AdRac1N17-infected, 96.3%). These results argue against a nonspecific effect of Rac1N17 on cell viability. Taken together, the above findings add strong support to the notion that VEGF signaling is critically dependent on Rac1-regulated NADPH oxidase activity.
DISCUSSION
Although ROS have traditionally been viewed as cytotoxic molecules, they are now recognized to play a critical role in signal transduction and transcriptional regulation within the vascular tree (1, 2) . ROS production in vascular smooth muscle cells is induced by a variety of stimuli, including angiotensin II (35) , thrombin (36) , and platelet-derived growth factor (37) . Agoniststimulated ROS have been shown to activate downstream signaling targets (38) (39) (40) , to induce the expression of redox-sensitive genes, and to mediate cell proliferation and migration (41) (42) (43) . In endothelial cells, ROS generation is induced by hemodynamic forces and cytokines (44) . Endothelium-derived ROS have been shown to affect phosphorylation of ERK1/ERK2 (45) and to increase the expression and/or DNA-binding of transcription factors such as NFκB and AP1 (23, (46) (47) (48) .
There is increasing evidence for an important role of NADPH oxidase in generating ROS within endothelial cells (49) . The NADPH oxidase complex consists of a membrane component comprising two subunits, gp91phox and p22phox, and several cytosolic components, including p40phox, p47phox, p67phox, and the small GTPase Rac (Rac1 or Rac2). Various components of the leukocyte NADPH oxidase complex have been identified in endothelial cells, including gp91phox, p47phox, and p22phox (50) (51) (52) . Moreover, numerous studies have provided evidence for the role of NADPH oxidase as the primary determinant of basal ROS generation in the endothelium (53) . Finally, temporal changes in NADPH oxidase activity and secondary increases in ROS production have been reported in studies of endothelial cells that were exposed to oscillatory and steady-state shear stress (54), cyclical strain (55), ischemia (23, 56, 57) , ΤΝF-. (21), or high concentrations of K + (57) .
In this study, we have shown that the addition of VEGF to two different primary endothelial cell types (HCAEC and HPAEC) resulted in a significant induction of MnSOD mRNA and protein.
This effect was blocked completely by the intracellular overexpression of the ROS scavenger enzymes, catalase, or Cu, Zn-SOD, suggesting that both O 2 -and H 2 O 2 are involved as signaling intermediates. We also demonstrated that VEGF transiently increased ROS levels in endothelial cells and that this effect was abrogated by overexpression of a dominant-negative form of the small GTPase component of the NADPH oxidase complex, Rac1 (Rac1N17).
The VEGF-mediated changes in ROS were modest and short-lived relative to the increase in MnSOD mRNA and protein. Similar disparities have been reported in other studies of redoxsensitive gene expression (58) (59) (60) , and may be explained by a number of factors. First and foremost, quantitative changes in upstream signaling events and downstream target gene expression are typically nonlinear. Second, DCF oxidation measures total cellular ROS and may thereby underestimate local production of O 2 -by Rac1-regulated NADPH oxidase at the level of the plasma membrane. Finally, VEGF induction of MnSOD was dependent on both inducible and basal levels of ROS. Overexpression of RacN17, which prevented the increase in ROS but did not decrease basal levels of ROS, only partially blunted the MnSOD response. In contrast, the addition of chemical inhibitors, which decreased inducible and basal levels of ROS, completely abrogated MnSOD induction. Together, our findings suggest that VEGF/ROSdependent increases in MnSOD expression are mediated, at least in part, by a Rac1-dependent oxidase and that VEGF signals through a pathway that is sensitive to both basal and inducible levels of NADPH oxidase-derived ROS.
To our knowledge, only one other study has examined the effect of VEGF on ROS production. Marumo et al. showed that VEGF stimulated ROS production in bovine retinal microvascular endothelial cells (34) . The response was abrogated by the addition of SOD and L-NAME and by the peroxynitrite scavenger urate. Their findings supported an important role for NOS in mediating VEGF-induced changes in ROS. In contrast, we have shown that pretreatment of HCAEC with L-NAME resulted in increased levels of ROS. Moreover, L-NAME did not inhibit VEGF-mediated induction of MnSOD and the addition of the NO donor SNAP had no effect on MnSOD mRNA levels. Taken together, these results argue against an important role of NOS in mediating MnSOD up-regulation in VEGF-treated HCAEC and suggest that the effect of VEGF on ROS generating pathways may vary between species and/or different sites of the vascular tree.
Our finding that VEGF signaling induces MnSOD expression has important biological implications. First, ROS have been shown to induce mitochondrial damage and dysfunction (61) , leading to impaired function of Krebs' cycle (62) and activation of apoptotic pathways (63) . Because MnSOD catalyzes the removal of O 2 -, the enzyme has the potential to enhance cell survival. Indeed, it is tempting to speculate that VEGF-mediated induction of MnSOD represents an important mechanism by which the growth factor exerts its anti-apoptotic effects (64) (65) (66) (67) . Second, VEGF-mediated increases in MnSOD activity would serve to enhance the local production of H 2 O 2 . Because H 2 O 2 readily diffuses between cellular compartments, newly generated H 2 O 2 would be free to interact with cytosolic signal transduction pathways. In other words, the mitochondria might function as signaling modules in VEGF-treated endothelial cells. Third, increased levels of MnSOD may protect the mitochondria from the toxic effects of peroxynitrite (ONOO -). VEGF has been shown to induce NO activity in endothelial cells (68, 69) . Newly generated NO may react with O 2 -to produce ONOO -, leading to endothelial cell dysfunction and mitochondrial damage (61, (70) (71) (72) (73) . SOD competes with NO for scavenging of O 2 -, thereby inhibiting the production of ONOO -and increasing the bioavailability of NO (74) . Considering the results of the present study, we propose that VEGF-mediated induction of MnSOD may offset the ROS-generating capacity of elevated NO. In other words, the coregulation of SOD expression and NO activity by VEGF may serve to reduce the prooxidant potential of NO and thus divert NO to biologically important functions. It would follow that VEGF-mediated changes in MnSOD may serve to attenuate further ROS production and protect against cytotoxicity.
In summary, we have demonstrated that VEGF induces MnSOD expression and that VEGF signaling requires a threshold level of NADPH oxidase-generated ROS. The study raises interesting questions that require further investigation: 1) How does the redox state influence other functions of VEGF? 2) What is the net effect of VEGF on the redox potential of the various subcellular compartments? 3) To what extent does VEGF alter the expression of other antioxidants in endothelial cells, such as Cu, Zn-SOD, catalase, or glutathione? 4) Does the redox state and its role in VEGF signaling vary between different types of endothelial cells? The answers to these questions should provide important insights about the role of VEGF and ROS in endothelial cell biology. Northern blot analysis of MnSOD in HCAEC, which were treated with vehicle (C) or with 50 ng/ml VEGF, 5 mM L-NAME or 500 µM SNAP. For vehicle treatment, cells were exposed to DMSO at concentrations equal to the highest concentrations used in the inhibitor studies. All membranes were subsequently stripped and probed with a radiolabeled 18S probe. (Bottom) MnSOD mRNA abundance was quantified by scanning densitometry. To correct for loading, MnSOD signal density was normalized to that of 18S ribosomal RNA. The ratio is expressed as fold-induction relative to control, untreated cells. Data represent mean ± SD from three experiments.
* P < 0.05 compared with control, untreated cells. † P < 0.05 compared with VEGFtreated cells. Rac1N17. HCAEC were infected with Adβgal, AdRac1N17 (A) or AdCat (B) at 100 MOI. A modified Boyden chamber was used to assess migratory activity in infected HCAEC exposed to 50 ng/ml VEGF. C) HCAEC were uninfected or infected with Adβgal or AdRac1N17 at 100 MOI and subsequently sorted by FACS for annexin V and PI staining. Viable cells are negative for both annexin V and PI (bottom left); early apoptotic cells are positive for annexin V and negative for PI (bottom right); late apoptotic/necrotic cells are positive for both annexin V and PI (upper right).
